According to phase 2 study, MariTide achieved significant weight loss in individuals with obesity or overweight, with up to ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...

KFF Health News staffers and contributors made the rounds on national and local media this week to discuss their stories.